DNA vaccines against GPRC5D synergize with PD-1 blockade to treat multiple myeloma

Abstract Multiple myeloma (MM), a hematological malignancy of the bone marrow, remains largely incurable. The orphan G protein-coupled receptor, GPRC5D, which is uniquely expressed in plasma cells and highly expressed in MM, is a compelling candidate for immunotherapy. In this study, we investigated...

書誌詳細
出版年:	npj Vaccines
主要な著者:	Praveen Neeli, Perry Ayn Mayson A. Maza, Dafei Chai, Dan Zhao, Xen Ping Hoi, Keith Syson Chan, Ken H. Young, Yong Li
フォーマット:	論文
言語:	英語
出版事項:	Nature Portfolio 2024-10-01
オンライン･アクセス:	https://doi.org/10.1038/s41541-024-00979-w

類似資料

Targeting GPRC5D for multiple myeloma therapy
著者:: Dian Zhou, 等
出版事項: (2024-09-01)

Lipid nanoparticles deliver DNA-encoded biologics and induce potent protective immunity
著者:: Dafei Chai, 等
出版事項: (2025-01-01)

Application of GPRC5D Targeting Therapy in Relapsed Refractory Multiple Myeloma
著者:: Sijia Yan, 等
出版事項: (2025-03-01)

PD-1 blockade synergizes with oxaliplatin-based, but not cisplatin-based, chemotherapy of gastric cancer
著者:: Peng Liu, 等
出版事項: (2022-12-01)

The binding mechanism of an anti-multiple myeloma antibody to the human GPRC5D homodimer
著者:: Pengfei Yan, 等
出版事項: (2024-06-01)

Non-homogenous intratumor ionizing radiation doses synergize with PD1 and CXCR2 blockade
著者:: Paul Bergeron, 等
出版事項: (2024-10-01)

Inosine shapes PD-1 blockade responses and synergizes with dual PD-1/CTLA-4 immunotherapy to enhance antitumor immunity
著者:: Yoichiro Narikawa, 等
出版事項: (2025-08-01)

GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review
著者:: Paula Rodriguez-Otero, 等
出版事項: (2024-02-01)

Correction: GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review
著者:: Paula Rodriguez-Otero, 等
出版事項: (2024-03-01)

326 Optimization of GPRC5D-targeted CAR T cells (OriCAR-017) for multiple myeloma
著者:: Yuting Zhang, 等
出版事項: (2023-11-01)

1182 Bispecific GPRC5D antibodies with potent cell-killing activity against multiple myeloma
著者:: Benjamin Doranz, 等
出版事項: (2023-11-01)

MDM2 inhibitor APG-115 synergizes with PD-1 blockade through enhancing antitumor immunity in the tumor microenvironment
著者:: Douglas D. Fang, 等
出版事項: (2019-11-01)

DNA-delivered monoclonal antibodies targeting the p53 R175H mutant epitope inhibit tumor development in mice
著者:: Dafei Chai, 等
出版事項: (2024-07-01)

Efficacy and safety of chimeric antigen receptor T cells targeting BCMA and GPRC5D in relapsed or refractory multiple myeloma
著者:: Xu Yang, 等
出版事項: (2024-12-01)

Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy
著者:: Maximilian Merz, 等
出版事項: (2024-12-01)

Stabilized iRGD modification enhances NY-ESO-1 TCR-T infiltration in solid tumors and synergizes with PD-1 blockade
著者:: Yirong Wu, 等
出版事項: (2025-05-01)

An immunomodulatory photosensitizer-mediated photodynamic therapy synergizes with PD-L1 blockade against metastatic triple-negative breast cancer
著者:: Yuetong Liu, 等
出版事項: (2025-07-01)

Bacteria Synergized with PD‐1 Blockade Enhance Positive Feedback Loop of Cancer Cells‐M1 Macrophages‐T Cells in Glioma
著者:: Qi Chen, 等
出版事項: (2024-05-01)

CaCO3 powder-mediated biomineralization of antigen nanosponges synergize with PD-1 blockade to potentiate anti-tumor immunity
著者:: Runping Su, 等
出版事項: (2023-04-01)

AI-powered discovery of a novel p53-Y220C reactivator
著者:: Shan Zhou, 等
出版事項: (2023-08-01)

Immunotherapies targeting GPRC5D in relapsed or refractory multiple myeloma: latest updates from 2022 ASH Annual Meeting
著者:: Jieyun Xia, 等
出版事項: (2023-06-01)

Osteocalcin binds to a GPRC6A Venus fly trap allosteric site to positively modulate GPRC6A signaling
著者:: Rupesh Agarwal, 等
出版事項: (2024-09-01)

Bacterial Infection-Mimicking Three-Dimensional Phagocytosis and Chemotaxis in Electrospun Poly(ε-caprolactone) Nanofibrous Membrane
著者:: Seung-Jun Lee, 等
出版事項: (2021-07-01)

Case Report: Summary of multiple CAR-T expansions in anti-BCMA/GPRC5D bispecific CAR-T cell therapy for multiple myeloma
著者:: Liya Wei, 等
出版事項: (2025-06-01)

GSH-responsive polymeric micelles-based augmented photoimmunotherapy synergized with PD-1 blockade for eliciting robust antitumor immunity against colon tumor
著者:: Chenlu Huang, 等
出版事項: (2024-09-01)

The changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody (bsAb) therapy in patients with relapsed refractory multiple myeloma
著者:: Lindsay Hammons, 等
出版事項: (2023-08-01)

The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects
著者:: Bowen Lu, 等
出版事項: (2024-02-01)

Correction: GSH-responsive polymeric micelles-based augmented photoimmunotherapy synergized with PD-1 blockade for eliciting robust antitumor immunity against colon tumor
著者:: Chenlu Huang, 等
出版事項: (2024-10-01)

GPRC5C regulates the composition of cilia in the olfactory system
著者:: Sneha Bhat, 等
出版事項: (2023-12-01)

GPRC6A: Jack of all metabolism (or master of none)
著者:: Min Pi, 等
出版事項: (2017-02-01)

Intermittent dietary methionine deprivation facilitates tumoral ferroptosis and synergizes with checkpoint blockade
著者:: Ying Xue, 等
出版事項: (2023-08-01)

A novel T cell-redirecting anti-GPRC5D × CD3 bispecific antibody with potent antitumor activity in multiple myeloma preclinical models
著者:: Urara Tomita, 等
出版事項: (2024-03-01)

Oncolytic virus expressing PD-1 inhibitors activates a collaborative intratumoral immune response to control tumor and synergizes with CTLA-4 or TIM-3 blockade
著者:: Jun Zhang, 等
出版事項: (2022-06-01)

Conventional amphotericin B elicits markers of immunogenic cell death on leukemic blasts, mediates immunostimulatory effects on phagocytic cells, and synergizes with PD-L1 blockade
著者:: G. Kofla, 等
出版事項: (2022-12-01)

S173: T-CELL ACTIVATION AND MYELOMA CELL KILLING CONFIRM THE MODE OF ACTION OF RG6234, A NOVEL GPRC5D T-CELL ENGAGING BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
著者:: I. Dekhtiarenko, 等
出版事項: (2022-06-01)

Remodeling of anti-tumor immunity with antibodies targeting a p53 mutant
著者:: Dafei Chai, 等
出版事項: (2024-06-01)

Synergic Renoprotective Effects of Combined ASC Therapy with RAAS Blockade in Experimental Advanced CKD
著者:: Marina P. C. Maires, 等
出版事項: (2022-01-01)

GPRC6A Mediates Glucose and Amino Acid Homeostasis in Mice
著者:: Yumin He, 等
出版事項: (2022-08-01)

845 ABL503 (TJ-L14B), PD-L1×4–1BB bispecific antibody, reinvigorates exhausted tumor-infiltrating CD8+ T cells and synergizes with PD-1 blockade
著者:: Seung Hyuck Jeon, 等
出版事項: (2023-11-01)

Bispecific antibodies targeting BCMA, GPRC5D, and FcRH5 for multiple myeloma therapy: latest updates from ASCO 2023 Annual Meeting
著者:: Juanjuan Zhao, 等
出版事項: (2023-08-01)